Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1982 Feb;58(676):100–101. doi: 10.1136/pgmj.58.676.100

Glandular fever-like syndrome, pulmonary eosinophilia and asthma associated with carbamazepine

I J Lewis, L Rosenbloom
PMCID: PMC2426303  PMID: 7100019

Abstract

An 8-year-old boy is described who developed hypersensitivity to carbamazepine manifested by fever, rash, lymphadenopathy, hepatosplenomegaly and asthma with eosinophilia. The abnormal reaction resolved rapidly following cessation of the drug.

Full text

PDF
100

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cullinan S. A., Bower G. C. Acute pulmonary hypersensitivity to carbamazepine. Chest. 1975 Oct;68(4):580–581. doi: 10.1378/chest.68.4.580. [DOI] [PubMed] [Google Scholar]
  2. Gayford J. J., Redpath T. H. The side-effects of carbamazepine. Proc R Soc Med. 1969 Jun;62(6):615–616. [PMC free article] [PubMed] [Google Scholar]
  3. Houwerzijl J., De Gast G. C., Nater J. P., Esselink M. T., Nieweg H. O. Lymphocyte-stimulation tests and patch tests to carbamazepine hypersensitivity. Clin Exp Immunol. 1977 Aug;29(2):272–277. [PMC free article] [PubMed] [Google Scholar]
  4. Lee T., Cochrane G. M., Amlot P. Pulmonary eosinophilia and asthma associated with carbamazepine. Br Med J (Clin Res Ed) 1981 Feb 7;282(6262):440–440. doi: 10.1136/bmj.282.6262.440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Rosenow E. C., 3rd The spectrum of drug-induced pulmonary disease. Ann Intern Med. 1972 Dec;77(6):977–991. doi: 10.7326/0003-4819-77-6-977. [DOI] [PubMed] [Google Scholar]
  6. Virolainen M. Blast transformation in vivo and in vitro in carbamazepin hypersensitivity. Clin Exp Immunol. 1971 Sep;9(3):429–435. [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES